Moderna
MRNA
#1630
Rank
A$16.05 B
Marketcap
$41.53
Share price
-2.41%
Change (1 day)
-73.25%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total debt

Total debt on the balance sheet as of December 2024 : A$1.23 Billion

According to Moderna 's latest financial reports the company's total debt is A$1.23 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Moderna - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2024-12-31A$1.20 B-34.17%
2023-12-31A$1.82 B3.46%
2022-12-31A$1.76 B39.57%
2021-12-31A$1.26 B309.93%
2020-12-31A$0.30 B63.03%
2019-12-31A$0.18 B297.69%
2018-12-31A$47.53 M136.58%
2017-12-31A$20.09 M15.87%
2016-12-31A$17.34 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$0.45 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
A$61.38 B 4,868.01%๐Ÿ‡บ๐Ÿ‡ธ USA
A$30.72 M-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.14 B 73.50%๐Ÿ‡บ๐Ÿ‡ธ USA
A$51.70 B 4,084.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$0.86 B-29.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$60.59 B 4,804.15%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA